Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, long-term illness that affects many body systems. People with ME/CFS are often not able to do their usual activities. At times, ME/CFS may confine them to bed. People with ME/CFS have severe fatigue and sleep problems. ME/CFS may get worse after people with the illness try to do as much as they want or need to do. This symptom is known as post-exertional malaise (PEM). Other symptoms can include problems with thinking and concentrating, pain, and dizziness.
According to an Institute of Medicine (IOM) report published in 2015, an estimated 836,000 to 2.5 million Americans suffer from ME/CFS, but most of them have not been diagnosed.
CDC is pleased to launch the third Medscape continuing medical education (CME) activity for healthcare providers “Diagnosing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experts Weigh In.”
The goal is to increase recognition of symptoms of ME/CFS by using the Institute of Medicine (IOM) diagnostic criteria for patient assessment. The faculty include Lucinda Bateman, MD, Natalie Azar, MD, Nancy Klimas, MD, and José Montoya, MD.
The video is intended for all healthcare providers with an emphasis on the primary care providers. The course, hosted by Medscape, provides CME/CE credit.
- NINDS/CDC Common Data Elements (CDEs) for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)external icon
- Disability and ME/CFS
- ME/CFS: Making strides to enhance the lives of those living with ME/CFS
- NIH Director’s Blog: Moving Toward Answers in ME/CFS, March 2017external icon
- NIH ME/CFS websiteexternal icon
- CFS Advisory Committee to HHSexternal icon
- FDA Voice of the Patient pdf icon[PDF – 267KB]external icon
- ME/CFS clinical trialsexternal icon
In Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illnessexternal icon, the committee proposes new diagnostic criteria that will facilitate timely diagnosis and care, and enhance understanding of this complex disease among health care providers and the public.